Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities
Net loss	$ (1,675,448)	$ (2,034,302)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	137,907	86,083
Amortization of intangible assets	176,757	0
Stock-based compensation	300,228	103,598
Changes in assets and liabilities
Accounts receivable	(1,271,909)	234
Inventories	(166,161)	(100,710)
Prepaids and other current assets	5,029	31,613
Refundable income taxes	(56,710)	0
Accounts payable	661,880	213,142
Accrued compensation and benefits	(81,088)	(188,314)
Accrued expenses	111,823	(16,390)
Deferred revenues	263,233	60,513
Net cash used in operating activities	(1,594,459)	(1,844,533)
Cash flows from investing activities
Expenditures for property and equipment	(601,804)	(75,755)
Net used in investing activities	(601,804)	(75,755)
Cash flows from financing activities
Proceeds from bank loans and notes payable	0	1,156,128
Repayments of bank loans and notes payable	(75,501)	(114,853)
Proceeds from issuance of debenture notes payable	0	517,168
Proceeds from issuance of Series A preferred stock	1,447,240	0
Common stock issuance costs	(65,304)	(157,311)
Net cash provided by financing activities	1,306,435	1,401,132
Effect of exchange rate changes on cash and cash equivalents	(52,399)	6,202
Net decrease in cash and cash equivalents	(942,227)	(512,954)
Cash and cash equivalents - beginning of period	2,910,595	1,235,635
Cash and cash equivalents - end of period	1,968,368	722,681
Cash paid for interest	59,668	32,007
Supplemental schedule of non-cash investing and financing activities:
Issuance of common stock for discounted notes receivable	1,440,960	514,255
Issuance of common stock as consideration for equity issuance costs	$ 0	$ 294,117